Efficacy Study of Condrosulf in the Treatment of Symptomatic OA of the Hand
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The goal of the present study is to investigate the effectiveness of Condrosulf® 800 mg
tablets vs. placebo once a day for 6 months in the symptomatic treatment of finger joint
osteoarthritis.
Primary endpoints of the study are the evaluation of global spontaneous pain (Huskisson's
Visual Analogue Scale: VAS) and the score of Dreiser's algo-functional index (FIHOA) during
the treatment with the tested product, Condrosulf®, versus placebo.